Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Nuvo Pharmaceuticals Inc MRVFF

Healthcare Drug Manufacturers - Specialty & Generic
Nuvo Pharmaceuticals Inc is a Canadian focused healthcare company doing business as Miravo Healthcare with global reach and a diversified portfolio of commercial products. Its product targets several therapeutic areas, including pain, allergy, and dermatology. The company's strategy is to in-license and acquire growth-oriented, complementary products for Canadian and international markets. see more

Bullboard (OTCQX:MRVFF)

View:
Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 Next
Post by lscfaon May 14, 2022 10:38am

$1.00 valuation

https://www.bloomburton.com/research/MRV20220513.pdf
386
Comment by VictorKonstanon May 13, 2022 6:19pm

RE:RE:Shameful…

Probably...but the way things are progressing under Ledger's illustrious leadership, I'm sure they will be worthless this time next year!!
229
Discussion
Comment by Marathon11on May 13, 2022 5:47pm

RE:Shameful…

Will they issue themselves options on Monday based on today's closing price which happens to conveniently be a 52 week plus low???
208
Discussion
Post by VictorKonstanon May 13, 2022 11:32am

Shameful…

This is what you get when lyin lazy Ledger sits on his butt and does nothing to increase shareholder value and the value of the company... He's been touting to increase capacity at the Varennes ...more  
338
Discussion
Post by VictorKonstanon Apr 18, 2022 5:04pm

Anyone still following this company…?

Obviously not much faith in current management and subsequently buying interest in this company's stock.  CEO has been touting to stay tuned for transformational pharma deals for well over a ...more  
358
Post by lscfaon Mar 28, 2022 9:52am

Audited results

Not explained......   Gross margin Commercial Q4 21 47.1% Q3 21 69.7% ...more  
275
Post by Betteryear2on Jan 24, 2022 8:34am

Named to 2022 OTCQX Best 50

January 24, 2022 08:10 AM Eastern Standard Time MISSISSAUGA, Ontario--(BUSINESS WIRE)--Nuvo Pharmaceuticals® Inc. (TSX:MRV; OTCQX:MRVFF) d/b/a Miravo Healthcare (Miravo or the Company) ...more  
235
Post by Marketwatchmanon Nov 14, 2021 10:00am

NUVO

Q3, 2021 , tomorrow 15-11-2021
273
Post by bmreedon Oct 30, 2021 12:25pm

Webinar MRV w CEO Scott Montgomery Nov 4 @ 1PM ET / 10AM PT

Webinar - Miravo (MRV) - formerly Nuvo Pharmaceuticals w/ Jesse Ledger CEO Thur Nov 4 at 1pm ET / 10am PT Q&A with Radius Research  Register Here - https://us02web.zoom.us/webinar ...more  
310
Comment by Marathon11on Jul 20, 2021 4:53pm

RE:RE:Prospectus

I hope you are right and my guess was wrong.... however, it was April 21 (approx. 90 days ago) that they filed the final base shelf prospectus. Just coincidence? Today's trading didn't exactly ...more  
320
Discussion
Comment by lscfaon Jul 08, 2021 8:39pm

RE:Prospectus

I've seen 2 yr shelf prospectuses expire unused. They are for contingency planning.   
246
Discussion
Comment by UglyKidStockon Jun 25, 2021 1:00pm

RE:RE:Prospectus

More insider buying in June.   Price going up  approaching August 15 second quarter release
307
Discussion
Comment by UglyKidStockon Jun 09, 2021 11:50am

RE:Prospectus

2021-05-28 Dobranowski, Anthony Edward 6,000 Buy in the public market at $1.45 per share $8,700.00 62,181 2021-05-26 ...more  
254
Discussion
Post by Marathon11on Jun 08, 2021 3:15pm

Prospectus

We are approaching 90 days since the prospectus was filed. In my opinion, it sure looks like the price has been manipulated over those 3 months. Sure hope they aren't going to dilute us at this ...more  
314
Discussion
Comment by lscfaon May 19, 2021 2:14pm

RE:Bloom raises target price

Bloom maintains target...   May 18/21 - We have made adjustments to our forecasts based on Miravo’s 1Q-2021 financial results. Target remains $2.60, and rating remains BUY (Speculative ...more  
407
Discussion
Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities